title: MitraClip intervention as rescue therapy in cardiogenic shock: one-year follow-up.
abstract: The MitraClip (Abbott Vascular, Menlo Park, CA) is a device used to perform transcatheter edge-to-edge repair of the mitral valve approved by the Food and Drug Administration for the treatment of high-risk degenerative mitral regurgitation. We describe the follow up of a 78-year-old man with severe functional mitral regurgitation and cardiogenic shock who underwent a successful MitraClip implantation.
authors.affiliation: Montreal Heart Institute, Montreal, Québec, Canada.
authors.forename: Philippe
authors.initials: P
authors.lastname: Couture
authors.affiliation: Montreal Heart Institute, Montreal, Québec, Canada.
authors.forename: Laurie-Ann
authors.initials: LA
authors.lastname: Cloutier-Gill
authors.affiliation: Montreal Heart Institute, Montreal, Québec, Canada.
authors.forename: Anique
authors.initials: A
authors.lastname: Ducharme
authors.affiliation: Montreal Heart Institute, Montreal, Québec, Canada.
authors.forename: Raoul
authors.initials: R
authors.lastname: Bonan
authors.affiliation: Montreal Heart Institute, Montreal, Québec, Canada. Electronic address: anita.asgar@umontreal.ca.
authors.forename: Anita W
authors.initials: AW
authors.lastname: Asgar
mesh_terms: D000368:Aged; D005500:Follow-Up Studies; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008943:Mitral Valve; D008944:Mitral Valve Insufficiency / Q000628:therapy; D012770:Shock, Cardiogenic / Q000628:therapy*